A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

Phase 2 Completed 8 enrolled Aldeyra Therapeutics, Inc.

RandomizedCrossoverQuadruple-blindTreatment

Summary

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of ADX-629 in Subjects with Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

Timeline

Start: 2021-01-09
Primary completion: 2022-01-18
Completion: 2022-01-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ACLOPROXALAP	Other / unclassified	600 mg	Oral

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

Summary

Timeline

Drugs

Indications